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and with positive and negative predictive values of 85.7 and 95.2%, respectively. CONCLUSIONS AND
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Background: In dogs with chronic valvular heart disease (CVHD), early recognition of pulmonary edema (PE) is of para-
mount importance. Recent studies in dogs showed that lung ultrasound examination (LUS) is a useful technique to diagnose
cardiogenic PE.
Objectives: To describe LUS features in dogs with diﬀerent stages of CVHD, and to determine its diagnostic accuracy in
detecting PE using thoracic radiography as the reference standard.
Animals: Sixty-three dogs with CVHD.
Methods: Prospective, multicenter, cross-sectional study. Each dog underwent physical examination, echocardiography,
thoracic radiography, and LUS. The LUS ﬁndings were classiﬁed as absent, rare, numerous, or conﬂuent B-lines. Sensitivity,
speciﬁcity, and positive and negative predictive values of LUS B-lines to identify PE were calculated using thoracic radiogra-
phy as the reference standard.
Results: Dogs in stage B1 had absent or rare B-lines in 14 of 15 cases (93.3%). Dogs in stage B2 had absent or rare B-lines in
16 of 18 cases (88.9%). All dogs in stage C, without radiographic signs of PE, had absent or rare B-lines. Dogs in stage C, with
radiographic signs of PE, had numerous or conﬂuent B-lines in 18 of 20 cases (90%). Lung ultrasound examination detected PE
with a sensitivity of 90%, speciﬁcity of 93%, and with positive and negative predictive values of 85.7 and 95.2%, respectively.
Conclusions and Clinical Importance: Lung ultrasound examination showed good diagnostic accuracy to identify cardio-
genic PE and might be helpful in staging dogs with CVHD. Lung ultrasound examination should be considered as a new,
noninvasive diagnostic tool for clinicians managing CVHD in dogs.
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Chronic valvular heart disease (CVHD) is the mostcommon acquired cardiac disease in dogs.1 The dis-
ease is characterized by a progressive degeneration of
the mitral valve, which leads to mitral regurgitation.
Mitral regurgitation can lead to cardiac remodeling and
development of congestive heart failure (CHF).
Although most dogs with CVHD remain asymptomatic
for years, approximately one-third develop CHF and
die from their heart disease.2 Thus, both early recogni-
tion and prompt treatment of cardiac remodeling and
CHF are of utmost clinical importance.3–5 Thoracic
radiography is the most commonly used method for the
diagnosis of cardiogenic pulmonary edema (PE) and
currently is considered the clinical standard for diagno-
sis of PE in dogs.6,7
In people, lung ultrasound examination (LUS) is used
in the diagnosis of acute respiratory failure both in
emergency medicine and cardiology.8–10 In people with
acute heart failure, LUS is used to assess and stage PE
with reliable results.11–13 In patients with PE, ultra-
sound identiﬁes artifacts that appear as vertical hypere-
choic lines with a narrow base that emerge from the
surface of the pleura, extending to the distal edge of the
screen, which are called B-lines.14–16 These B-lines cor-
respond to the thickening of the subpleural and inter-
lobular septa or to the presence of extravascular ﬂuid in
the lungs.12,14 Studies in people indicate that the num-
ber and distribution of B-lines correlate with pulmonary
capillary wedge pressure, the presence of extravascular
ﬂuid in the lungs, and the severity of clinical presenta-
tion and prognosis.15,17–19 Some patients with interstitial
PE develop B-lines before the onset of clinical or radio-
graphic signs of heart failure; LUS may be of clinical
utility in the early diagnosis of PE in these cases.17
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LVIDDn normalized left ventricular internal diameter in diastole
PE pulmonary edema
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In veterinary medicine, LUS initially was used in
horses to evaluate recurrent airway obstruction, exer-
cise-induced pulmonary hemorrhage, pulmonary ﬁbro-
sis, and interstitial pneumonia.20 Recent studies in dogs
indicate that LUS may be a useful technique to aid in
the diagnosis of cardiogenic PE.21–23 However, to the
best of our knowledge, no studies have described LUS
ﬁndings in dogs with preclinical CVHD as compared to
dogs in CHF.
The aims of our study were to describe LUS features
in dogs with diﬀerent stages of CVHD in accordance
with the ACVIM consensus classiﬁcation system, and to
determine the diagnostic accuracy of LUS to detect PE
using thoracic radiography as the reference standard.
Materials and Methods
The study protocol and informed consent were reviewed and
approved by the Institutional Welfare and Ethics Committee of
the University of Pisa (permission number 33472/2016).
Dogs were prospectively recruited from August 2015 to Septem-
ber 2016 at the Department of Veterinary Sciences of the University
of Pisa and the Department of Cardiology of the Istituto Veteri-
nario di Novara. Each dog underwent a physical examination,
echocardiography, thoracic radiography, and LUS examination.
Inclusion criteria were the presence of a typical heart murmur
and an echocardiographic diagnosis of CVHD, characterized by
degenerative changes in the mitral valve leaﬂets, mitral valve pro-
lapse, and the presence of systolic mitral regurgitant ﬂow.24
Collected echocardiographic data were normalized left ventricu-
lar internal diameter in diastole (LVIDDn), left atrial-to-aortic
root ratio (LA/Ao), and ﬂow data including peak velocity of E
wave of transmitral ﬂow (Emax) and E wave to A wave ratio of
transmitral ﬂow (E/A ratio).
Dogs with CVHD were classiﬁed into stages B1, B2, C, and D
according to the ACVIM classiﬁcation scheme.6 Stage B was
deﬁned as subclinical heart disease without (B1) or with (B2) evi-
dence of left cardiomegaly, deﬁned as LA/Ao ≥ 1.6,25
LVIDDn > 1.73,26 or both. Dogs were assigned to stage C if they
had a history or current clinical signs of CHF in conjunction with
past or current evidence of PE on thoracic radiographs. Finally,
dogs with past or current evidence of PE on thoracic radiographs
that had been treated and relapsed or failed to respond to the ini-
tial treatment were classiﬁed as stage D.6
Dogs with pleural eﬀusion were excluded from the study. More-
over, dogs with another concomitant heart disease in addition to
CVHD were excluded.
Latero-lateral and orthogonal (ventrodorsal or dorsoventral)
radiographic views of the thorax were evaluated. A board-certiﬁed
radiologist (E.A) and a radiologist (S.C) reviewed the images inde-
pendently. All studies were randomly ordered and radiologists
were blinded to the animal’s history, examination date, initial
radiological interpretation and echocardiographic diagnosis, as
well as LUS ﬁndings. After interpreting the ﬁlms, the 2 readers’
results were compared. If there was disagreement with regard to
the presence or absence of CHF, the two radiologists collectively
reassessed the images to arrive at a ﬁnal deﬁnitive diagnosis that
satisﬁed both readers. Radiographic patterns of PE were classiﬁed
according to location as follows: diﬀuse (when all the lung ﬁelds
were involved), perihilar (when only the region surrounding the
lung hilum was involved), or focal (when a single area of ≥1 lung
lobes was involved).27
Each dog underwent LUS examination on the same day that
echocardiography and thoracic radiography were performed. The
imaging examinations were performed with no clinically relevant
time delay and no additional medical interventions for PE treat-
ment in between. Two sonographers (T.M., E.A.) performed the
LUS studies using linear probesa,b with two diﬀerent ultrasound
machines.c,d To avoid lung atelectasis caused by recumbency, dogs
were positioned in standing position and manually restrained. Hair
was not clipped; alcohol and gel were used as coupling agents.
Each hemithorax was examined by sliding the probe from dorsal
to ventral, examining all intercostal spaces. Based on a previous
study,22 the presence of B-lines was evaluated as follows: absent
(no B-lines per hemithorax); rare (≤3 B-lines per hemithorax);
numerous (>3 B-lines per hemithorax); and conﬂuent (multiple B-
lines blended together per hemithorax) (Fig 1). When we detected
diﬀerent LUS ﬁndings between the 2 hemithoraces, the most sev-
ere ﬁnding was assigned.
Statistical Analysis
The normality of data distribution was tested using the
Shapiro–Wilk test. Descriptive statistics were generated. A value
of P < .05 was considered statistically signiﬁcant.
Diﬀerences in continuous data among dogs with diﬀerent stages
of CVHD (B1, B2 and C) were determined by one-way analysis of
variance with subsequent comparisons using Tukey’s multiple
comparisons test (for normally distributed data) or by the
Kruskal–Wallis test, with subsequent comparisons using the Dunn
test (for non-normally distributed data). For categorical variables,
a comparison among diﬀerent stages of CVHD was performed
using Fisher’s exact tests.
To test the diagnostic accuracy of LUS in the detection of PE,
dogs were divided into the following two groups: absent/rare B-
lines versus numerous/conﬂuent B-lines.8,13,22,23,28 The sensitivity,
speciﬁcity, and positive and negative predictive values of LUS to
detect PE were calculated using thoracic radiography as the refer-
ence standard.
For the statistical analyses, commercial softwaree was used.
Results
The study included 63 dogs with a diagnosis of CVHD:
15 dogs in ACVIM stage B1, 18 dogs in ACVIM stage
Fig 1. Lung ultrasound images. (A) Absent B-lines (no B-lines). (B) Rare B-lines (≤3 B-lines). (C) Numerous B-lines (>3 B-lines).
(D) Conﬂuent B-lines (multiple B-lines blended together).
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B2, and 30 dogs in ACVIM stage C. A total of 20 of 30
dogs in ACVIM stage C (66.7%) had radiographic signs
of PE. In dogs with PE, 14 of 20 (70%) had a focal radio-
graphic pattern of location, 3 of 20 (15%) a diﬀuse loca-
tion and 3 of 20 (15%) a perihilar location. Baseline
clinical characteristics of the dogs are presented in
Table 1. There were no statistically signiﬁcant diﬀerences
among groups in terms of sex, age and body weight.
Regarding echocardiographic data, dogs in stage C had a
signiﬁcantly higher value of LA/Ao (median, 2.30; range,
1.75–3.68) in comparison with stage B2 (median, 1.80;
range, 1.60–2.80) (P < .001) and stage B1 (median, 1.39;
range, 1.00–1.50) (P < .001). Left atrial dimension in
stage B2 was signiﬁcantly larger than stage B1
(P < .001). The peak E wave velocity of the diastolic
transmitral ﬂow was signiﬁcantly higher in stage C (me-
dian, 1.51 m/s; range, 0.66, 2.30 m/s) in comparison with
stage B2 (median, 0.98 m/s; range, 0.40–2.04 m/s)
(P < .001) and stage B1 (median, 0.89 m/s; range, 0.66–
1.02 m/s) (P < .001). Similarly, the E wave to A wave
ratio of the transmitral ﬂow was signiﬁcantly higher only
in stage C (median, 2.04; range, 0.67–4.20) in comparison
with stage B2 (median, 1.10; range, 0.70–3.00) (P < .001)
and B1 (median, 1.33; range, 0.75–1.65) (P < .001).
Lastly, dogs in stage C had a higher value of LVIDDn
(median, 2.21; range, 1.63–2.86) in comparison with stage
B2 (median, 1.87; range, 1.39–2.34); (P < .001) and stage
B1 (median, 1.48; range, 1.25–1.85); (P < .001). The
LVIDDn in stage B2 was signiﬁcantly larger than in stage
B1 (P < .001).
The LUS ﬁndings in our sample population are pre-
sented in Table 2. Dogs in stage B1 had absent or rare
B-lines in 93.3% of cases (14/15). More speciﬁcally,
73.3% (11/15) had absent B-lines and 20% (3/15) had
rare B-lines. Only 6.7% of dogs in stage B1 (1/15)
showed numerous B-lines. Dogs in stage B2 had absent
or rare B-lines in 88.9% of cases (16/18). Speciﬁcally,
66.7% of dogs in stage B2 (12/18) had absent B-lines
and 22.2% (4/18) had rare B-lines. Only 11.1% of dogs
in stage B2 (2/18) showed numerous B-lines. Similarly,
all dogs in stage C (10/10), without radiographic signs
of PE, had absent or rare B-lines. Of the dogs in stage
C without radiographic signs of PE, 60% (6/10) had
absent B-lines and 40% (4/10) had rare B-lines. Dogs in
stage C with radiographic signs of PE showed numer-
ous or conﬂuent B-lines in 90% of cases (18/20), with
55% (11/20) showing numerous B-lines and 20% (7/20)
showing conﬂuent B-lines, only 10% (2/20) had rare B-
lines.
Lung ultrasound examination had a 90.0% sensitivity
and 93.0% speciﬁcity in diﬀerentiating dogs with or
without PE as assessed by thoracic radiography, with
positive predictive value of 85.7% and negative predic-
tive value of 95.2% (Table 3).
Discussion
To the authors’ knowledge, ours is the ﬁrst study
describing LUS ﬁndings in dogs with diﬀerent stages of
CVHD in accordance with the ACVIM classiﬁcation
scheme. We found that the majority of dogs in stages
B1 and B2 had absent or rare B-lines. Similarly, all
dogs in stage C without radiographic signs of PE had
absent or rare B-lines. Conversely, the majority of dogs
in stage C with radiographic signs of PE had numerous
or conﬂuent B-lines. These results are in agreement with
ﬁndings in human patients in whom the number of B-
lines increases with a worsening of the heart failure
class,9,29 and PE is diagnosed when numerous or conﬂu-
ent B-lines are detected.8,9,18 Similarly, previous studies
in dogs have shown that cardiogenic PE is associated
with numerous or conﬂuent B-lines on LUS. However,
these studies only compared healthy dogs and dogs with
radiographic signs of PE.21–23
In our study, LUS had good diagnostic accuracy in
the detection of PE in dogs with CVHD, with sensitiv-
ity of 90.0% and speciﬁcity of 93.0%. To our
Table 1. Clinical, echocardiographic, and radiographic
data of all dogs (n = 63).
Stage B1
(n = 15)
Stage B2
(n = 18)
Stage C
(n = 20)
Male/
Female
7/8 11/7 20/10
Age (years) 11.5 (6.0–15.0) 11 (6.0–16.0) 11 (5.0–18.0)
BW (kg) 12 (3.5–40.0) 10 (4.5–27.0) 9 (3.7–37.0)
LA/Ao 1.39 (1.00–1.50) 1.8 (1.60–2.80)a 2.3 (1.75–3.68)a,b
Emax (m/s) 0.89 (0.66–1.02) 0.98 (0.40–2.04) 1.51 (0.66–2.30)a,b
E/A ratio 1.33 (0.75–1.65) 1.10 (0.70–3.00) 2.04 (0.67–4.20)a,b
LVIDDn 1.48 (1.25–1.85) 1.87 (1.39–2.34)a 2.21 (1.63–2.86)a,b
PE (%) 0 (0%) 0 (0%) 20 (66.7%)a,b
BW, body weight; LA/Ao, left atrium to aortic root ratio;
Emax, peak velocity of E wave of the transmitral ﬂow; E/A, E
wave to A wave ratio of the transmitral ﬂow; LVIDDn, normal-
ized left ventricular internal diameter in diastole; PE, pulmonary
edema.
Data are expressed as the median (range) or number (percent-
age).
aP < .05 as compared to stage B1.
bP < .05 as compared to stage B2.
Table 2. B-lines of all dogs (n = 63).
Stage B1
(n = 15)
Stage B2
(n = 18)
Stage C
(noPE)
(n = 10)
Stage C
(PE)
(n = 20)
Absent/rare 14 (93.3%) 16 (88.9%) 10 (100%) 2 (10%)
Numerous/
conﬂuent
1 (6.7%) 2 (11.1%) 0 (0%) 18 (90%)
noPE, absence of pulmonary edema; PE, pulmonary edema.
Table 3. Diagnostic accuracy of LUS in the detection
of pulmonary edema (n = 63).
No PE (n = 43) PE (n = 20)
Absent/rare 40 (93%) 2 (10%)
Numerous/conﬂuent 3 (7%) 18 (90%)
Sensitivity 90.0%; speciﬁcity 93.0%; positive predictive value
85.7%; negative predictive value 95.2%.
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knowledge, no previous studies have described the diag-
nostic accuracy of LUS in the detection of PE in dogs
with diﬀerent stages of CVHD. Our results are similar
to ﬁndings in people where the sensitivity and speciﬁcity
of LUS in detecting PE were 83–97% and 83–100%,
respectively.8,16,28,30,31
In our study, a few dogs in stage B1 (6.7%, 1/15)
and B2 (11.1%, 2/18) had numerous B-lines. A possible
explanation might be the presence of an underlying pul-
monary disease other than cardiogenic PE that was not
detected by conventional radiography. B-lines have been
described in people and horses with pulmonary ﬁbrosis,
acute respiratory distress syndrome, pulmonary hemor-
rhages, pneumonia, or lung cancer.13,18,20,32 Another
possible explanation for dogs in stages B1 and B2 with
numerous B-lines might be the presence of mild cardio-
genic PE, which was not detected by thoracic radiogra-
phy. Although thoracic radiography is considered the
reference standard for the diagnosis of PE in clinical
practice, inter-reader variability may occur.7,33 Studies
in humans indicate that thoracic radiography can be
less sensitive than LUS in identifying the presence of
cardiogenic PE.30
Our study did not ﬁnd 100% sensitivity of LUS for
the detection of PE, similar to the literature in
people.8,16,28–31 Two dogs in stage C with radiographic
evidence of PE exhibited only rare B-lines on LUS in
our study. In both cases, the pulmonary inﬁltrate was
only perihilar. It is hypothesized that in patients with
only perihilar edema, normally ventilated peripheral
lung tissue prevents B-lines, which would otherwise be
visible if pathologic pulmonary parenchyma was present
along the thoracic wall, from being seen.
We recognize that our study has some limitations.
The number of dogs enrolled was relatively small. How-
ever, the sample population was homogeneous. Indeed,
only dogs with CVHD were included. It is assumed that
a larger number of dogs would have provided similar
results. Moreover, intra- and interobserver variability
during the LUS acquisition was not evaluated. The
evaluation of the number of B-lines might have been
partially biased by the operator. However, many studies
in people have shown that intra- and interobserver vari-
ability is clinically acceptable if the procedure is per-
formed by trained operators.34–36 A linear probe was
used in all dogs for the LUS examination. However,
currently no consensus exists in the veterinary literature
regarding the best type of probe to be used for LUS.21–23
The results of our study may have diﬀered slightly
using another type of probe, but linear high frequency
probes are thought to provide the best resolution for
scanning superﬁcial structures. Lastly, we used thoracic
radiography as the reference method to evaluate the
pulmonary parenchyma. Computed tomography is a
more sensitive and speciﬁc technique than thoracic
radiography to diagnose cardiogenic PE.37 However,
both in people and in dogs, thoracic radiography is the
ﬁrst line procedure to assess pulmonary congestion,
and computed tomography is not a routine technique
in patients with heart failure, especially in acute
PE.1,6,37
Our ﬁndings indicate that LUS has good diagnostic
accuracy in identifying cardiogenic PE and might be
useful in the staging of dogs with CVHD. Lung ultra-
sound examination is a new, quick, and noninvasive
diagnostic tool for the cardiologist, radiologist, or
intensive care specialist. It should be considered as com-
plementary to thoracic radiography, and particularly
useful when radiographic ﬁndings are unclear or in
severely dyspneic dogs. In the future, it would be inter-
esting to evaluate the utility of LUS in the chronic
management and serial monitoring of dogs with CVHD
under treatment.
Footnotes
a 18L7, 10–14 MHz, Toshiba, Monza Brianza
b 9L-D, 2.4–10.0 MHz, GE Healthcare, Milano
c Aplio, Toshiba, Monza Brianza
d Logiq S8, GE Healthcare, Milano
e GraphPad Prism 5
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